Deep cfDNA fragment end profiling enables cancer detection
Scientists from the Department of genomics of adaptive immunity of the IBCH RAS together with colleagues from the Pirogov Russian National Research Medical University, N.N. Blokhin Russian Cancer Research Center and Federal Center for Brain and Neurotechnology developed a method for detecting tumors at an early stage in the human body by the structural features of cell-free DNA (сfDNA) ends. The researchers studied the ends of the сfDNA fragments in specific genomic regions at high resolution, and based on their sequences and position in the genome, were able to distinguish between samples from healthy donors and cancer patients in a group of 175 individuals. The developed method for cfDNA ends profiling makes it possible to detect colorectal cancer and kidney cancer using a blood plasma sample at the early stages of the disease. The study was published in Molecular Cancer.
11 февраля 2022 года